In the US, Rapaflo (silodosin systemic) is a member of the drug class antiadrenergic agents, peripherally acting and is used to treat Benign Prostatic Hyperplasia.
US matches:
- Rapaflo
Ingredient matches for Rapaflo
Silodosin
Silodosin is reported as an ingredient of Rapaflo in the following countries:
- United States
International Drug Name Search
No comments:
Post a Comment